搜索

x

一种负载Temporin-GHaR的CMCS/HPMC/P407/P188复合水凝胶制备及其抗菌作用

Preparation of CMCS/HPMC/P407/P188 thermosensitive injectable composite hydrogel with Temporin-GHaR and its antibacterial effects

  • 摘要: 为了解决Temporin-GHaR稳定性差及溶血毒性高的问题,采用制剂设计技术,构建了负载Temporin-GHaR的温敏型羧甲基壳聚糖/羟丙基甲基纤维素/泊洛沙姆四元复合水凝胶CMCS/HPMC/P407/P188(CHPP/GHaR)。经响应面法优化配方,制得的水凝胶具多孔纤维网络结构,兼备剪切稀化、自愈合与可注射性,溶胀率良好。结果表明:释放实验显示,CHPP/GHaR突释风险低;生物相容性评价证实,负载200 μmol·L−1 GHaR的水凝胶溶血率低,且对角质形成细胞与脐静脉血管上皮细胞无明显细胞毒性;体外抗菌实验显示,CHPP/GHaR对耐甲氧西林金黄色葡萄球菌、大肠杆菌和铜绿假单胞菌的抑菌率超99%。研究结果可为耐药菌感染治疗提供新型候选材料。

     

    Abstract: In order to solve the problems of the antimicrobial peptide Temporin-GHaR that stability is poor and the hemolytic toxicity is high, in the report, the preparation design technology was used to construct a thermosensitive quaternary composite hydrogel of carboxymethyl chitosan/hydroxypropyl methylcellulose/poloxamer loaded with Temporin-GHaR (CHPP/GHaR). The response surface method was used to optimize the formulation, the obtained hydrogel with a porous fiber network structure exhibited shear-thinning, self-healing, and injectability, and the swelling rate was 161.5%. The drug release tests showed a sustained release of 55% within 40 hours with low burst release risk. Biocompatibility evaluation test confirmed that the hydrogel loaded with 200 μmol·L-1 GHaR had only 2.2% hemolysis rate and no significant cytotoxicity to keratinocytes and umbilical vein endothelial cells. In vitro antimicrobial experiments demonstrated that CHPP/GHaR achieved above 99% inhibition rates against methicillin-resistant Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, the inhibition rates of which were more than 10 times higher than that of the control. Our findings provide a new candidate material for the treatment of the resistant bacterial. infections.

     

/

返回文章
返回